All results
1 results for stronger study
-
NYMC-571
This is a follow-up trial to NYMC 526 (NCT01461837) to assess the safety, efficacy and toxicity of administering Defibrotide prophylaxis for high-risk sickle…
- Ages
- 6 Months - 34 Years
- Sexes
- All